Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
OvoControl
Product Overview
Development Status:
Inactive
Target:
Female
Mode:
Non-hormonal
Delivery Type:
Oral
Duration Type:
Short-acting
Description:
A modified version of a drug currently approved as an anti-protozoal and contraceptive for avians that may alter sperm receptor proteins.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
nicarbazin
Potential Multi-Purpose Technology (MPT):
No
Regimen:
daily
Partner:
Innolytics LLC
Status
Project Phase:
Discovery
Project Stage:
Target ID/Validation
Status Details:
Testing was done in rats. As in birds, the rat ovaries collected 4,4A-dinitrocarbanilide (DNC), the bioactive moiety in nicarbazin. However, contraceptive effectiveness in mammals could not be confirmed. Innolytics is not currently pursuing further work on OvoControl as a contraceptive in humans.
Programmatic Considerations
Additional Information
Additional Information:
Innolytics, LLC website
Download Product Report
